PwC December 12, 2018
Meg Bryant

Dive Brief:

  • The U.S. healthcare industry can expect more stability in 2019 as FDA and CMS streamline regulation and healthcare investors strike deals with cash from last year’s tax reform law, but challenges remain, PwC’s 2019 health industry issues report says.
  • Political wrangling over U.S. healthcare won’t be resolved in 2019, leaving states to set policy directions. Organizations operating in more than one state may be hard pressed to develop comprehensive business strategies.
  • Meanwhile, consumers want more choices in how they receive care, with 78% saying they would opt to receive hospital care at home if it cost less than an inpatient stay, according to a survey by PwC’s Health Research Institute. More than half (54%) of consumers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Apps, CMS, Digital Health, FDA, Govt Agencies, Health System / Hospital, Home, Patient / Consumer, Physician, Provider, Regulations, Technology, Trends
Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s
‘Think about the hype’ - AI holds disruptive potential for health care
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Experts: Mind these 4 health and safety focus areas
Hospice Handoffs May Lower Odds of Medicare Denials

Share This Article